Navigation Links
Varian Medical Systems Has Received CE Mark for Proton Therapy System
Date:2/19/2009

PALO ALTO, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) today announced that it has received CE mark for the Varian Proton Therapy System, which is designed to help doctors to improve treatments and outcomes in many cancer cases. With proton therapy, doctors can use higher doses of radiation to control and manage tumors while significantly reducing damage to healthy tissue and vital organs.

"CE mark is an important milestone in Varian's initiative to develop and market a compact system capable of intensity-modulated proton therapy in single- or multi-room facilities," said Lester Boeh, vice president of emerging businesses for the company. "This is a clear demonstration of our ongoing commitment to provide the cancer treatment community and its patients with a clinically practical and commercially viable proton therapy system that meets accepted safety standards for medical equipment."

The CE mark makes it possible for cancer treatment centers to begin ordering, installing, and using the Varian Proton Therapy System in regions where CE mark is required without having to obtain a site-specific clearance to use this important technology. "Varian is actively marketing the Varian Proton Therapy System, and institutions from all parts of the world are pursuing this promising technology for cancer patients in their regions," Boeh said.

Through research and development and the acquisition of ACCEL in Germany during 2007, Varian has developed a comprehensive proton therapy system that utilizes the company's technology for particle beam generation, treatment planning, imaging, motion management, and information management technology.

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Public Cancer Center Becomes First in South-East Asia to Introduce RapidArc Radiotherapy Treatments From Varian Medical Systems
2. Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer
3. Garry W. Rogerson Elected Chairman of the Board of Varian, Inc.
4. Fertility Drugs Do Not Increase Ovarian Cancer Risk
5. Angiogenesis linked to poor survival in patients with rare type of ovarian cancer
6. Top Belgian Cancer Center Becomes First in Country to Introduce RapidArc Radiotherapy Treatments From Varian Medical Systems
7. Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2009
8. Fujirebio Diagnostics and Abbott Agree To Develop New Ovarian Cancer Test for Abbotts Architect(R) Analyzers
9. Gene Variant Raises Risk for Brain Cancer at Young Age
10. Varian Medical Systems and BrainLAB to Showcase Novalis Tx(TM) Platform for Non-Invasive Image-Guided Radiosurgery
11. A Fast, New Cancer Fighting Tool Is Now Available in the Houston Area: RapidArc(TM) Radiotherapy Technology from Varian Medical Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... Delhi, India (PRWEB) August 30, 2014 ... introduced low cost SEO service for small businesses. , ... or start-ups cannot afford costly search engine optimization service. ... budget of small businesses into account. , On ... said, “We have introduced this low cost SEO service ...
(Date:8/30/2014)... 2014 The establishment and creation ... been one of the main strategies of the ... positive impact around the world. , Architecturally stellar ... trained executives and trainers deliver L. Ron Hubbard's ... Vital statistics demonstrate that significant reduction in crime, ...
(Date:8/30/2014)... Acne is a common problem millions of American cope ... than a daily nuisance, for some, it can have a crippling ... even lead to dramatic mood swings and depression. , Those ... up their skin. In some cases, that can make the problem ... error, those on a quest for clearer skin can now view ...
(Date:8/30/2014)... VA (PRWEB) August 30, 2014 Seniors Guide, ... articles recently that focus on Alzheimer’s Disease, Dementia, and ... revealed to the public of being diagnosed with the Alzheimer’s, ... latest movie, “I’ll Be Me”. The movie, out on ... while focusing on his diagnosis of the disease – which ...
(Date:8/30/2014)... Manhattan Beach, Calif. (PRWEB) August 30, 2014 ... Carol Francis helps listeners understand how they unknowingly developed insomnia ... and have restful nights during. Tune in to the ... . The show airs live on August 30, and ... For more information on programming, go to DrCarolFrancisTalkRadio.com. ...
Breaking Medicine News(10 mins):Health News:RBSEO Services Introduces Low Cost SEO Service for Small Businesses 2Health News:Cradle of Aviation Museum Opens Its Doors to Long Island Scientologists 2Health News:Acne Treatment Reviews Added to Popular Treatment Website 2Health News:Alzheimer’s Disease and Dementia Focus on Retirement Website SeniorsGuideOnline.com 2Health News:Sleepless Nights, Exhausting Days, Mental Fog – Relief for Insomnia With Clinical Psychologist Dr. Carol Francis 2
... , WEDNESDAY, Sept. 9 (HealthDay News) -- Young athletes ... cardiac death triggered by vigorous exercise, new Dutch research ... of death in young athletes, but no one knows ... reporting does not exist, the study authors noted. , ...
... Sept. 9 Reducing the risk of counterfeit drugs and contaminated medications ... the pharmaceutical and life sciences industries today, according to a new ... More than 50 percent of executives polled say their companies fail to ... their supply chain. , , (Logo: ...
... , LEWISTON, Maine and THOUSAND OAKS, Calif., Sept. 9 ... Challenge: A Journey for Hope, a cycling and 5K fundraising event scheduled ... Center for Cancer Hope & Healing at Central Maine Medical Center. ... Amgen,s Breakaway from Cancer ((R)) initiative, which aims to ...
... , FRANKLIN, Mass., Sept. 9 ... management company developing the needle-free Symphony(TM) tCGM System as ... and the Prelude(TM) SkinPrep System for transdermal drug delivery, ... at the Rodman & Renshaw 2009 Annual Global Investment ...
... , , , PORTLAND, Ore., Sept. ... chief executive officer of Regence BlueCross BlueShield: , , ... a pivotal conversation about health care reform. I applaud our nation,s ... "This August we saw an unfortunate polarization of our country. ...
... Calling all walkers, joggers, bikers and avid health & exercise buffs. Calling all couch potatoes, procrastinators, perpetual dieters and failed boot camp recruits! ... ... Thursday, September 10th, ... University Mall, ...
Cached Medicine News:Health News:Testing Young Athletes for Heart Defects May Save Lives 2Health News:IBM Study Reveals Drug Companies Struggle to Improve Supply Chain to Battle Counterfeiting, Safety Concerns and Global Complexity 2Health News:IBM Study Reveals Drug Companies Struggle to Improve Supply Chain to Battle Counterfeiting, Safety Concerns and Global Complexity 3Health News:IBM Study Reveals Drug Companies Struggle to Improve Supply Chain to Battle Counterfeiting, Safety Concerns and Global Complexity 4Health News:Amgen Named Presenting Sponsor of The Dempsey Challenge: A Journey For Hope 2Health News:Amgen Named Presenting Sponsor of The Dempsey Challenge: A Journey For Hope 3Health News:Amgen Named Presenting Sponsor of The Dempsey Challenge: A Journey For Hope 4Health News:Echo Therapeutics Announces New Presentation Time at Rodman & Renshaw 2009 Annual Global Investment Conference 2Health News:Health Insurer Regence Continues to Advocate for Meaningful Health Reform 2Health News:Grand Opening: An Exercise Program for People Who Just Love To Dance 2
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- SAM Medical ... Strap for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today that it ... to address a potential issue with a clip ... the Axilla application of the SAM Junctional Tourniquet ...
(Date:8/29/2014)... Aug. 29, 2014  A Boston Scientific Corporation ... on stent removability and preliminary long term stricture ... in the August issue of the peer-reviewed journal, ... is being conducted in 11 countries and ... self-expanding metal stents (FCSEMS) after extended indwell (i.e., ...
(Date:8/29/2014)... Aug. 29, 2014 Medina Medical announced today ... member of the Board of Directors on August 18, ... development and commercialization experience, including over a decade of ... served as a Partner of the medical device incubator ... of two Foundry start-ups. Mr. Engelson previously served as ...
Breaking Medicine Technology:SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2
... 18, 2011 The National Association of Chain ... Association (NCPA) have sent a joint letter ... explaining the importance of pharmacies in Medicaid, offering ... to cut costs without endangering Medicaid beneficiaries, access ...
... Cornerstone Therapeutics Inc. (Nasdaq: CRTX ) today ... AM ET on Thursday, March 3, 2011, to discuss its ... 31, 2010. Financial results are expected to be released on ... financial markets. To participate in the live conference ...
Cached Medicine Technology:NACDS, NCPA Provide Insights to Governors and State Medicaid Directors Confronting Medicaid Budgetary Challenges 2NACDS, NCPA Provide Insights to Governors and State Medicaid Directors Confronting Medicaid Budgetary Challenges 3Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call 2Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call 3
The NexGen CR femoral component is intended for patients who, in the physician's judgement, have good bone stock and whose ligaments provide adequate mediolateral, anteroposterior, and varus/valgus s...
Primary knee system, symmetrical in design....
Cruciate retaining, posterior stabilized and constrained components....
Maximum contact. Minimum wear. Outstanding results....
Medicine Products: